 Free Email Alerts By Stock:
Get Dividend Alerts 
Get SEC Filing Alerts
|
|
|
Thursday 12/13 Insider Buying Report: RETA, ARMK Thursday, December 13, 10:31 AM ET Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned dollars to make a purchase, is that they expect to make money. Today we look at two noteworthy recent insider buys.
On Wednesday, Reata Pharmaceuticals (RETA)'s , James W. Traweek Jr., made a $6.58M buy of RETA, purchasing 110,826 shares at a cost of $59.41 a piece. So far Traweek Jr. is in the green, up about 6.2% on their buy based on today's trading high of $63.11. Reata Pharmaceuticals is trading up about 1.8% on the day Thursday. Before this latest buy, Traweek Jr. purchased RETA at 3 other times during the past twelve months, for a total investment of $6.15M at an average of $25.18 per share.
And also on Wednesday, CEO Eric J. Foss purchased $3.00M worth of Aramark (ARMK), purchasing 92,564 shares at a cost of $32.46 a piece. This purchase marks the first one filed by Foss in the past twelve months. Aramark is trading up about 2.2% on the day Thursday. Foss was up about 2.1% on the buy at the high point of today's trading session, with ARMK trading as high as $33.14 in trading on Thursday.
For MarketNewsVideo.com, I'm Sayoko Murase. | |
 | |
Launch related slideshow:
Symbol Cloud:
ABEO
ACET
ADC
AFL
ALAB
ALHC
AMN
AMRK
ANGO
ANRO
ARWR
ASLE
ATEC
ATOS
AUB
AUBN
AVBP
AXR
AYI
AYX
BANC
BHRB
BHVN
BLND
BRTX
BY
CATX
CET
CHTR
CIO
CIVB
CLF
CLSD
CMP
CNXC
CODI
COLB
COOK
CRMT
CROX
CSPI
CSV
CTRI
D
DAR
DC
DCTH
DINO
DLTR
DSGN
DVN
EG
EL
ELAN
ENPH
ENV
EPSN
ESOA
EVC
EVLV
EXEL
EXFY
EYEN
FAST
FINS
FLGC
FLO
FMC
FSK
FULC
GENK
GEO
GLO
GME
GO
GSAT
GT
GTN
HCI
HIW
HNRG
HWBK
OPK
RBB
TRDA
ULS
VFC
WBA
WLKP
|
